core kit Search Results


93
TaKaRa cycleave pcr core kit page 4
Cycleave Pcr Core Kit Page 4, supplied by TaKaRa, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cycleave pcr core kit page 4/product/TaKaRa
Average 93 stars, based on 1 article reviews
cycleave pcr core kit page 4 - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

94
Jena Bioscience taq core kit
Taq Core Kit, supplied by Jena Bioscience, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/taq core kit/product/Jena Bioscience
Average 94 stars, based on 1 article reviews
taq core kit - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

91
Valiant Co Ltd taq core kit 10
Taq Core Kit 10, supplied by Valiant Co Ltd, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/taq core kit 10/product/Valiant Co Ltd
Average 91 stars, based on 1 article reviews
taq core kit 10 - by Bioz Stars, 2026-03
91/100 stars
  Buy from Supplier

92
Boster Bio ek1117
Ek1117, supplied by Boster Bio, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ek1117/product/Boster Bio
Average 92 stars, based on 1 article reviews
ek1117 - by Bioz Stars, 2026-03
92/100 stars
  Buy from Supplier

93
Valiant Co Ltd taq core kit
Taq Core Kit, supplied by Valiant Co Ltd, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/taq core kit/product/Valiant Co Ltd
Average 93 stars, based on 1 article reviews
taq core kit - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

90
TaKaRa synthetic sirna quantitation core kit
Blood circulation and tumour accumulation profiles of uPIC. a – d IVCLSM images of circulating <t>A647-siRNA</t> in the blood vessels of the mouse ear dermis. Naked A647-siRNA at 30 s ( a ) and 60 min ( b ) after systemic injection. A647-siRNA/uPIC (A/P = 10) at 30 s ( c ) and 60 min ( d ) after systemic injection. The scale bars indicate 100 µm. e Time-dependent change in A647 fluorescence obtained by quantitatively analysing the IVCLSM images. f Time-dependent change in the FRET signal in the vein of the mouse ear dermis after systemic injection of FRET-siRNA/uPIC. g Biodistribution of naked Cy5-siRNA and Cy5-siRNA/uPIC 48 h after systemic administration. Fluorescence intensities were normalised to those obtained from naked siRNA. Data represent the means ± s.e.m. n = 4. h Time-dependent tumour accumulation profiles of naked Cy5-siRNA, uPIC, and Invivofectamine ® LNP. The fluorescence intensity was obtained from the regions of interest (ROI) in the continuous IVCLSM images (Supplementary Fig. ). i – k Spatial profiling of fluorescence intensity derived from Cy5-siRNA in tumour tissues at the initial stage (dashed line) and 10 h (solid line) after systemic administration of naked siRNA ( i ), uPIC ( j ), and LNP ( k ). The fluorescence intensities were measured along the direction of the white arrow in the IVCLSM image inset (red: Cy5-siRNA; green: GFP-BxPC3 cells; scale bar: 100 µm) and normalised to the maximum value obtained at the initial stage. The cancer cell nest region was identified by GFP fluorescence derived from cancer cells, as depicted by the dashed line in the IVCLSM image inset. l , m Subcellular distribution of naked Cy5-siRNA ( l ) or Cy5-siRNA/uPIC ( m ). The circular voids are cellular nuclei identified from the nuclei-stained CLSM image inset. The scale bars indicate 20 µm. n Cellular uptake efficiency of siRNA in a spheroid culture of BxPC3 cells. The cellular uptake efficiency was determined by qRT-PCR as the amount of Argonaute 2-bound siRNA <t>(or</t> <t>antisense</t> strand) and normalised to the value obtained from the cells treated with naked siRNA. Data represent the means ± s.d. n = 3
Synthetic Sirna Quantitation Core Kit, supplied by TaKaRa, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/synthetic sirna quantitation core kit/product/TaKaRa
Average 90 stars, based on 1 article reviews
synthetic sirna quantitation core kit - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
TaKaRa nucleospin robot 96 plasmid core kit
Blood circulation and tumour accumulation profiles of uPIC. a – d IVCLSM images of circulating <t>A647-siRNA</t> in the blood vessels of the mouse ear dermis. Naked A647-siRNA at 30 s ( a ) and 60 min ( b ) after systemic injection. A647-siRNA/uPIC (A/P = 10) at 30 s ( c ) and 60 min ( d ) after systemic injection. The scale bars indicate 100 µm. e Time-dependent change in A647 fluorescence obtained by quantitatively analysing the IVCLSM images. f Time-dependent change in the FRET signal in the vein of the mouse ear dermis after systemic injection of FRET-siRNA/uPIC. g Biodistribution of naked Cy5-siRNA and Cy5-siRNA/uPIC 48 h after systemic administration. Fluorescence intensities were normalised to those obtained from naked siRNA. Data represent the means ± s.e.m. n = 4. h Time-dependent tumour accumulation profiles of naked Cy5-siRNA, uPIC, and Invivofectamine ® LNP. The fluorescence intensity was obtained from the regions of interest (ROI) in the continuous IVCLSM images (Supplementary Fig. ). i – k Spatial profiling of fluorescence intensity derived from Cy5-siRNA in tumour tissues at the initial stage (dashed line) and 10 h (solid line) after systemic administration of naked siRNA ( i ), uPIC ( j ), and LNP ( k ). The fluorescence intensities were measured along the direction of the white arrow in the IVCLSM image inset (red: Cy5-siRNA; green: GFP-BxPC3 cells; scale bar: 100 µm) and normalised to the maximum value obtained at the initial stage. The cancer cell nest region was identified by GFP fluorescence derived from cancer cells, as depicted by the dashed line in the IVCLSM image inset. l , m Subcellular distribution of naked Cy5-siRNA ( l ) or Cy5-siRNA/uPIC ( m ). The circular voids are cellular nuclei identified from the nuclei-stained CLSM image inset. The scale bars indicate 20 µm. n Cellular uptake efficiency of siRNA in a spheroid culture of BxPC3 cells. The cellular uptake efficiency was determined by qRT-PCR as the amount of Argonaute 2-bound siRNA <t>(or</t> <t>antisense</t> strand) and normalised to the value obtained from the cells treated with naked siRNA. Data represent the means ± s.d. n = 3
Nucleospin Robot 96 Plasmid Core Kit, supplied by TaKaRa, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/nucleospin robot 96 plasmid core kit/product/TaKaRa
Average 90 stars, based on 1 article reviews
nucleospin robot 96 plasmid core kit - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

94
Qiagen puregene core kit 158 767
Blood circulation and tumour accumulation profiles of uPIC. a – d IVCLSM images of circulating <t>A647-siRNA</t> in the blood vessels of the mouse ear dermis. Naked A647-siRNA at 30 s ( a ) and 60 min ( b ) after systemic injection. A647-siRNA/uPIC (A/P = 10) at 30 s ( c ) and 60 min ( d ) after systemic injection. The scale bars indicate 100 µm. e Time-dependent change in A647 fluorescence obtained by quantitatively analysing the IVCLSM images. f Time-dependent change in the FRET signal in the vein of the mouse ear dermis after systemic injection of FRET-siRNA/uPIC. g Biodistribution of naked Cy5-siRNA and Cy5-siRNA/uPIC 48 h after systemic administration. Fluorescence intensities were normalised to those obtained from naked siRNA. Data represent the means ± s.e.m. n = 4. h Time-dependent tumour accumulation profiles of naked Cy5-siRNA, uPIC, and Invivofectamine ® LNP. The fluorescence intensity was obtained from the regions of interest (ROI) in the continuous IVCLSM images (Supplementary Fig. ). i – k Spatial profiling of fluorescence intensity derived from Cy5-siRNA in tumour tissues at the initial stage (dashed line) and 10 h (solid line) after systemic administration of naked siRNA ( i ), uPIC ( j ), and LNP ( k ). The fluorescence intensities were measured along the direction of the white arrow in the IVCLSM image inset (red: Cy5-siRNA; green: GFP-BxPC3 cells; scale bar: 100 µm) and normalised to the maximum value obtained at the initial stage. The cancer cell nest region was identified by GFP fluorescence derived from cancer cells, as depicted by the dashed line in the IVCLSM image inset. l , m Subcellular distribution of naked Cy5-siRNA ( l ) or Cy5-siRNA/uPIC ( m ). The circular voids are cellular nuclei identified from the nuclei-stained CLSM image inset. The scale bars indicate 20 µm. n Cellular uptake efficiency of siRNA in a spheroid culture of BxPC3 cells. The cellular uptake efficiency was determined by qRT-PCR as the amount of Argonaute 2-bound siRNA <t>(or</t> <t>antisense</t> strand) and normalised to the value obtained from the cells treated with naked siRNA. Data represent the means ± s.d. n = 3
Puregene Core Kit 158 767, supplied by Qiagen, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/puregene core kit 158 767/product/Qiagen
Average 94 stars, based on 1 article reviews
puregene core kit 158 767 - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

90
Jena Bioscience pfu x core kit
Blood circulation and tumour accumulation profiles of uPIC. a – d IVCLSM images of circulating <t>A647-siRNA</t> in the blood vessels of the mouse ear dermis. Naked A647-siRNA at 30 s ( a ) and 60 min ( b ) after systemic injection. A647-siRNA/uPIC (A/P = 10) at 30 s ( c ) and 60 min ( d ) after systemic injection. The scale bars indicate 100 µm. e Time-dependent change in A647 fluorescence obtained by quantitatively analysing the IVCLSM images. f Time-dependent change in the FRET signal in the vein of the mouse ear dermis after systemic injection of FRET-siRNA/uPIC. g Biodistribution of naked Cy5-siRNA and Cy5-siRNA/uPIC 48 h after systemic administration. Fluorescence intensities were normalised to those obtained from naked siRNA. Data represent the means ± s.e.m. n = 4. h Time-dependent tumour accumulation profiles of naked Cy5-siRNA, uPIC, and Invivofectamine ® LNP. The fluorescence intensity was obtained from the regions of interest (ROI) in the continuous IVCLSM images (Supplementary Fig. ). i – k Spatial profiling of fluorescence intensity derived from Cy5-siRNA in tumour tissues at the initial stage (dashed line) and 10 h (solid line) after systemic administration of naked siRNA ( i ), uPIC ( j ), and LNP ( k ). The fluorescence intensities were measured along the direction of the white arrow in the IVCLSM image inset (red: Cy5-siRNA; green: GFP-BxPC3 cells; scale bar: 100 µm) and normalised to the maximum value obtained at the initial stage. The cancer cell nest region was identified by GFP fluorescence derived from cancer cells, as depicted by the dashed line in the IVCLSM image inset. l , m Subcellular distribution of naked Cy5-siRNA ( l ) or Cy5-siRNA/uPIC ( m ). The circular voids are cellular nuclei identified from the nuclei-stained CLSM image inset. The scale bars indicate 20 µm. n Cellular uptake efficiency of siRNA in a spheroid culture of BxPC3 cells. The cellular uptake efficiency was determined by qRT-PCR as the amount of Argonaute 2-bound siRNA <t>(or</t> <t>antisense</t> strand) and normalised to the value obtained from the cells treated with naked siRNA. Data represent the means ± s.d. n = 3
Pfu X Core Kit, supplied by Jena Bioscience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pfu x core kit/product/Jena Bioscience
Average 90 stars, based on 1 article reviews
pfu x core kit - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

92
Bio-Rad clamp kit
Blood circulation and tumour accumulation profiles of uPIC. a – d IVCLSM images of circulating <t>A647-siRNA</t> in the blood vessels of the mouse ear dermis. Naked A647-siRNA at 30 s ( a ) and 60 min ( b ) after systemic injection. A647-siRNA/uPIC (A/P = 10) at 30 s ( c ) and 60 min ( d ) after systemic injection. The scale bars indicate 100 µm. e Time-dependent change in A647 fluorescence obtained by quantitatively analysing the IVCLSM images. f Time-dependent change in the FRET signal in the vein of the mouse ear dermis after systemic injection of FRET-siRNA/uPIC. g Biodistribution of naked Cy5-siRNA and Cy5-siRNA/uPIC 48 h after systemic administration. Fluorescence intensities were normalised to those obtained from naked siRNA. Data represent the means ± s.e.m. n = 4. h Time-dependent tumour accumulation profiles of naked Cy5-siRNA, uPIC, and Invivofectamine ® LNP. The fluorescence intensity was obtained from the regions of interest (ROI) in the continuous IVCLSM images (Supplementary Fig. ). i – k Spatial profiling of fluorescence intensity derived from Cy5-siRNA in tumour tissues at the initial stage (dashed line) and 10 h (solid line) after systemic administration of naked siRNA ( i ), uPIC ( j ), and LNP ( k ). The fluorescence intensities were measured along the direction of the white arrow in the IVCLSM image inset (red: Cy5-siRNA; green: GFP-BxPC3 cells; scale bar: 100 µm) and normalised to the maximum value obtained at the initial stage. The cancer cell nest region was identified by GFP fluorescence derived from cancer cells, as depicted by the dashed line in the IVCLSM image inset. l , m Subcellular distribution of naked Cy5-siRNA ( l ) or Cy5-siRNA/uPIC ( m ). The circular voids are cellular nuclei identified from the nuclei-stained CLSM image inset. The scale bars indicate 20 µm. n Cellular uptake efficiency of siRNA in a spheroid culture of BxPC3 cells. The cellular uptake efficiency was determined by qRT-PCR as the amount of Argonaute 2-bound siRNA <t>(or</t> <t>antisense</t> strand) and normalised to the value obtained from the cells treated with naked siRNA. Data represent the means ± s.d. n = 3
Clamp Kit, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/clamp kit/product/Bio-Rad
Average 92 stars, based on 1 article reviews
clamp kit - by Bioz Stars, 2026-03
92/100 stars
  Buy from Supplier

94
Trevigen tacs 2 tdt core kit
Blood circulation and tumour accumulation profiles of uPIC. a – d IVCLSM images of circulating <t>A647-siRNA</t> in the blood vessels of the mouse ear dermis. Naked A647-siRNA at 30 s ( a ) and 60 min ( b ) after systemic injection. A647-siRNA/uPIC (A/P = 10) at 30 s ( c ) and 60 min ( d ) after systemic injection. The scale bars indicate 100 µm. e Time-dependent change in A647 fluorescence obtained by quantitatively analysing the IVCLSM images. f Time-dependent change in the FRET signal in the vein of the mouse ear dermis after systemic injection of FRET-siRNA/uPIC. g Biodistribution of naked Cy5-siRNA and Cy5-siRNA/uPIC 48 h after systemic administration. Fluorescence intensities were normalised to those obtained from naked siRNA. Data represent the means ± s.e.m. n = 4. h Time-dependent tumour accumulation profiles of naked Cy5-siRNA, uPIC, and Invivofectamine ® LNP. The fluorescence intensity was obtained from the regions of interest (ROI) in the continuous IVCLSM images (Supplementary Fig. ). i – k Spatial profiling of fluorescence intensity derived from Cy5-siRNA in tumour tissues at the initial stage (dashed line) and 10 h (solid line) after systemic administration of naked siRNA ( i ), uPIC ( j ), and LNP ( k ). The fluorescence intensities were measured along the direction of the white arrow in the IVCLSM image inset (red: Cy5-siRNA; green: GFP-BxPC3 cells; scale bar: 100 µm) and normalised to the maximum value obtained at the initial stage. The cancer cell nest region was identified by GFP fluorescence derived from cancer cells, as depicted by the dashed line in the IVCLSM image inset. l , m Subcellular distribution of naked Cy5-siRNA ( l ) or Cy5-siRNA/uPIC ( m ). The circular voids are cellular nuclei identified from the nuclei-stained CLSM image inset. The scale bars indicate 20 µm. n Cellular uptake efficiency of siRNA in a spheroid culture of BxPC3 cells. The cellular uptake efficiency was determined by qRT-PCR as the amount of Argonaute 2-bound siRNA <t>(or</t> <t>antisense</t> strand) and normalised to the value obtained from the cells treated with naked siRNA. Data represent the means ± s.d. n = 3
Tacs 2 Tdt Core Kit, supplied by Trevigen, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tacs 2 tdt core kit/product/Trevigen
Average 94 stars, based on 1 article reviews
tacs 2 tdt core kit - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

90
Cusabio aggrecan core protein agc1 elisa kit
Blood circulation and tumour accumulation profiles of uPIC. a – d IVCLSM images of circulating <t>A647-siRNA</t> in the blood vessels of the mouse ear dermis. Naked A647-siRNA at 30 s ( a ) and 60 min ( b ) after systemic injection. A647-siRNA/uPIC (A/P = 10) at 30 s ( c ) and 60 min ( d ) after systemic injection. The scale bars indicate 100 µm. e Time-dependent change in A647 fluorescence obtained by quantitatively analysing the IVCLSM images. f Time-dependent change in the FRET signal in the vein of the mouse ear dermis after systemic injection of FRET-siRNA/uPIC. g Biodistribution of naked Cy5-siRNA and Cy5-siRNA/uPIC 48 h after systemic administration. Fluorescence intensities were normalised to those obtained from naked siRNA. Data represent the means ± s.e.m. n = 4. h Time-dependent tumour accumulation profiles of naked Cy5-siRNA, uPIC, and Invivofectamine ® LNP. The fluorescence intensity was obtained from the regions of interest (ROI) in the continuous IVCLSM images (Supplementary Fig. ). i – k Spatial profiling of fluorescence intensity derived from Cy5-siRNA in tumour tissues at the initial stage (dashed line) and 10 h (solid line) after systemic administration of naked siRNA ( i ), uPIC ( j ), and LNP ( k ). The fluorescence intensities were measured along the direction of the white arrow in the IVCLSM image inset (red: Cy5-siRNA; green: GFP-BxPC3 cells; scale bar: 100 µm) and normalised to the maximum value obtained at the initial stage. The cancer cell nest region was identified by GFP fluorescence derived from cancer cells, as depicted by the dashed line in the IVCLSM image inset. l , m Subcellular distribution of naked Cy5-siRNA ( l ) or Cy5-siRNA/uPIC ( m ). The circular voids are cellular nuclei identified from the nuclei-stained CLSM image inset. The scale bars indicate 20 µm. n Cellular uptake efficiency of siRNA in a spheroid culture of BxPC3 cells. The cellular uptake efficiency was determined by qRT-PCR as the amount of Argonaute 2-bound siRNA <t>(or</t> <t>antisense</t> strand) and normalised to the value obtained from the cells treated with naked siRNA. Data represent the means ± s.d. n = 3
Aggrecan Core Protein Agc1 Elisa Kit, supplied by Cusabio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/aggrecan core protein agc1 elisa kit/product/Cusabio
Average 90 stars, based on 1 article reviews
aggrecan core protein agc1 elisa kit - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


Blood circulation and tumour accumulation profiles of uPIC. a – d IVCLSM images of circulating A647-siRNA in the blood vessels of the mouse ear dermis. Naked A647-siRNA at 30 s ( a ) and 60 min ( b ) after systemic injection. A647-siRNA/uPIC (A/P = 10) at 30 s ( c ) and 60 min ( d ) after systemic injection. The scale bars indicate 100 µm. e Time-dependent change in A647 fluorescence obtained by quantitatively analysing the IVCLSM images. f Time-dependent change in the FRET signal in the vein of the mouse ear dermis after systemic injection of FRET-siRNA/uPIC. g Biodistribution of naked Cy5-siRNA and Cy5-siRNA/uPIC 48 h after systemic administration. Fluorescence intensities were normalised to those obtained from naked siRNA. Data represent the means ± s.e.m. n = 4. h Time-dependent tumour accumulation profiles of naked Cy5-siRNA, uPIC, and Invivofectamine ® LNP. The fluorescence intensity was obtained from the regions of interest (ROI) in the continuous IVCLSM images (Supplementary Fig. ). i – k Spatial profiling of fluorescence intensity derived from Cy5-siRNA in tumour tissues at the initial stage (dashed line) and 10 h (solid line) after systemic administration of naked siRNA ( i ), uPIC ( j ), and LNP ( k ). The fluorescence intensities were measured along the direction of the white arrow in the IVCLSM image inset (red: Cy5-siRNA; green: GFP-BxPC3 cells; scale bar: 100 µm) and normalised to the maximum value obtained at the initial stage. The cancer cell nest region was identified by GFP fluorescence derived from cancer cells, as depicted by the dashed line in the IVCLSM image inset. l , m Subcellular distribution of naked Cy5-siRNA ( l ) or Cy5-siRNA/uPIC ( m ). The circular voids are cellular nuclei identified from the nuclei-stained CLSM image inset. The scale bars indicate 20 µm. n Cellular uptake efficiency of siRNA in a spheroid culture of BxPC3 cells. The cellular uptake efficiency was determined by qRT-PCR as the amount of Argonaute 2-bound siRNA (or antisense strand) and normalised to the value obtained from the cells treated with naked siRNA. Data represent the means ± s.d. n = 3

Journal: Nature Communications

Article Title: In vivo rendezvous of small nucleic acid drugs with charge-matched block catiomers to target cancers

doi: 10.1038/s41467-019-09856-w

Figure Lengend Snippet: Blood circulation and tumour accumulation profiles of uPIC. a – d IVCLSM images of circulating A647-siRNA in the blood vessels of the mouse ear dermis. Naked A647-siRNA at 30 s ( a ) and 60 min ( b ) after systemic injection. A647-siRNA/uPIC (A/P = 10) at 30 s ( c ) and 60 min ( d ) after systemic injection. The scale bars indicate 100 µm. e Time-dependent change in A647 fluorescence obtained by quantitatively analysing the IVCLSM images. f Time-dependent change in the FRET signal in the vein of the mouse ear dermis after systemic injection of FRET-siRNA/uPIC. g Biodistribution of naked Cy5-siRNA and Cy5-siRNA/uPIC 48 h after systemic administration. Fluorescence intensities were normalised to those obtained from naked siRNA. Data represent the means ± s.e.m. n = 4. h Time-dependent tumour accumulation profiles of naked Cy5-siRNA, uPIC, and Invivofectamine ® LNP. The fluorescence intensity was obtained from the regions of interest (ROI) in the continuous IVCLSM images (Supplementary Fig. ). i – k Spatial profiling of fluorescence intensity derived from Cy5-siRNA in tumour tissues at the initial stage (dashed line) and 10 h (solid line) after systemic administration of naked siRNA ( i ), uPIC ( j ), and LNP ( k ). The fluorescence intensities were measured along the direction of the white arrow in the IVCLSM image inset (red: Cy5-siRNA; green: GFP-BxPC3 cells; scale bar: 100 µm) and normalised to the maximum value obtained at the initial stage. The cancer cell nest region was identified by GFP fluorescence derived from cancer cells, as depicted by the dashed line in the IVCLSM image inset. l , m Subcellular distribution of naked Cy5-siRNA ( l ) or Cy5-siRNA/uPIC ( m ). The circular voids are cellular nuclei identified from the nuclei-stained CLSM image inset. The scale bars indicate 20 µm. n Cellular uptake efficiency of siRNA in a spheroid culture of BxPC3 cells. The cellular uptake efficiency was determined by qRT-PCR as the amount of Argonaute 2-bound siRNA (or antisense strand) and normalised to the value obtained from the cells treated with naked siRNA. Data represent the means ± s.d. n = 3

Article Snippet: The antisense strands of siRNA in the sample solution were reverse-transcribed using a Synthetic siRNA Quantitation Core Kit (Takara Bio Inc., Shiga, Japan) and quantified by FastStart Universal SYBR Green Master (Roche, Basel, Switzerland) according to the manufacturers’ protocols.

Techniques: Injection, Fluorescence, Derivative Assay, Staining, Quantitative RT-PCR